🇺🇸 FDA
Patent

US 11020461

Methods and compositions for CNS delivery of arylsulfatase A

granted A61KA61K38/465A61K9/0019

Quick answer

US patent 11020461 (Methods and compositions for CNS delivery of arylsulfatase A) held by Takeda Pharmaceutical Company Limited expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/465, A61K9/0019, A61K9/0085, A61P